Urosphere Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 19


  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Urosphere General Information


Operator of a research organization intended to offer treatment in preclinical urogenital, gastro-intestinal, and oncological pharmacology assays. The company's unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues, establishes preclinical proof of concept for drug candidates, enabling pharmaceutical and biopharmaceutical industries to maintain a trustworthy relationship with partners and provide the highest quality services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Corporate Office
  • Canal Biotech Ii 3
  • Rue Des Satellites
  • 31400 Toulouse
  • France
+33 05 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Urosphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Urosphere’s complete valuation and funding history, request access »

Urosphere Executive Team (4)

Name Title Board Seat Contact Info
Philippe Lluel Ph.D Co-Founder, Chief Executive Officer & President
You’re viewing 1 of 4 executive team members. Get the full list »

Urosphere Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Urosphere Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nubbo Accelerator/Incubator Minority 000 0000 000000 0
To view Urosphere’s complete investors history, request access »

Urosphere Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ixaltis 27-Jul-2018 00000 0000 00.000 Drug Discovery 00000000
Urolead 23-Nov-2017 Merger/Acquisition Biotechnology 00000000
To view Urosphere’s complete investments and acquisitions history, request access »

Urosphere FAQs

  • When was Urosphere founded?

    Urosphere was founded in 2004.

  • Who is the founder of Urosphere?

    Philippe Lluel Ph.D and Stefano Palea are the founders of Urosphere.

  • Who is the CEO of Urosphere?

    Philippe Lluel Ph.D is the CEO of Urosphere.

  • Where is Urosphere headquartered?

    Urosphere is headquartered in Toulouse, France.

  • What is the size of Urosphere?

    Urosphere has 19 total employees.

  • What industry is Urosphere in?

    Urosphere’s primary industry is Biotechnology.

  • Is Urosphere a private or public company?

    Urosphere is a Private company.

  • What is Urosphere’s current revenue?

    The current revenue for Urosphere is 00000.

  • Who are Urosphere’s investors?

    Nubbo has invested in Urosphere.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »